Israel Englander Meridian Bioscience Inc Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$31.15 - $33.39 $10.2 Million - $10.9 Million	327,429 Added 41.4%	1,118,328 $37.1 Million
Q3 2022 Nov 14, 2022	BUY	$30.9 - $33.55 $22.7 Million - $24.6 Million	733,435 Added 1276.34%	790,899 $24.9 Million
Q2 2022 Aug 15, 2022	BUY	$23.75 - $31.69 $1.36 Million - $1.82 Million	57,464 New	57,464 $1.75 Million
Q1 2022 May 16, 2022	SELL	$19.97 - $26.94 $607,766 - $819,891	-30,434 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$17.46 - $21.61 $4.21 Million - $5.21 Million	-241,108 Reduced 88.79%	30,434 $621,000
Q3 2021 Nov 15, 2021	SELL	$17.35 - $22.5 $2.25 Million - $2.92 Million	-129,745 Reduced 32.33%	271,542 $5.22 Million
Q2 2021 Aug 16, 2021	BUY	$18.01 - $28.32 $1.15 Million - $1.81 Million	64,056 Added 18.99%	401,287 $8.9 Million
Q1 2021 May 17, 2021	SELL	$19.76 - $29.89 $1.91 Million - $2.89 Million	-96,757 Reduced 22.29%	337,231 $8.85 Million
Q4 2020 Feb 16, 2021	BUY	$15.73 - $21.66 $6.59 Million - $9.07 Million	418,838 Added 2764.61%	433,988 $8.11 Million
Q3 2020 Nov 16, 2020	SELL	$13.54 - $26.41 $9.02 Million - $17.6 Million	-666,074 Reduced 97.78%	15,150 $257,000
Q2 2020 Aug 14, 2020	SELL	$7.84 - $23.29 $3.82 Million - $11.3 Million	-487,161 Reduced 41.7%	681,224 $15.9 Million
Q1 2020 May 14, 2020	BUY	$5.57 - $11.5 $5.6 Million - $11.6 Million	1,005,374 Added 616.75%	1,168,385 $9.81 Million
Q4 2019 Feb 14, 2020	BUY	$7.9 - $10.14 $1.06 Million - $1.36 Million	133,897 Added 459.91%	163,011 $1.59 Million
Q3 2019 Nov 14, 2019	BUY	$9.17 - $12.01 $266,975 - $349,659	29,114 New	29,114 $276,000
Q2 2019 Aug 14, 2019	SELL	$10.88 - $17.6 $298,721 - $483,225	-27,456 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$15.51 - $17.61 $40,729 - $46,243	2,626 Added 10.58%	27,456 $484,000
Q4 2018 Feb 14, 2019	SELL	$14.52 - $19.72 $3.65 Million - $4.95 Million	-251,193 Reduced 91.0%	24,830 $431,000
Q3 2018 Nov 14, 2018	SELL	$14.85 - $16.35 $2.49 Million - $2.74 Million	-167,745 Reduced 37.8%	276,023 $4.11 Million
Q2 2018 Aug 14, 2018	SELL	$13.8 - $16.8 $5.46 Million - $6.65 Million	-395,841 Reduced 47.15%	443,768 $7.06 Million
Q1 2018 May 15, 2018	SELL	$13.8 - $16.2 $4.06 Million - $4.77 Million	-294,156 Reduced 25.95%	839,609 $11.9 Million
Q4 2017 Feb 14, 2018	BUY	$13.55 - $15.8 $5.45 Million - $6.36 Million	402,430 Added 55.03%	1,133,765 $15.9 Million
Q3 2017 Nov 14, 2017	BUY	$13.45 - $14.35 $9.84 Million - $10.5 Million	731,335	731,335 $10.5 Million

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account